Abstract Background Coronavirus disease 2019 (COVID-19) continues to pose a significant
threat to public health worldwide. The purpose of this study was to review current evidence …

Despite aggressive efforts on containment measures for the coronavirus disease 2019
(COVID-19) pandemic around the world, severe acute respiratory syndrome coronavirus 2 …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
worldwide pandemic since 2019, spreading rapidly and posing a significant threat to human …

Only a few treatments are approved for coronavirus disease‐2019 (COVID‐19) infections,
with continuous debate about their clinical impact. Repurposing antiviral treatments might …

Background: Randomized trial evidence suggests that some antiviral drugs are effective in
patients with COVID-19. However, the comparative effectiveness of antiviral drugs in …

Due to the lack of an etiologic treatment for SARS-CoV-2 and the difficulties involved in
developing new drugs, some drugs already approved for other diseases or with efficacy …

This systematic review and meta-analysis examined the efficacy of sofosbuvir-based
antiviral treatment against COVID-19 (coronavirus disease 2019). PubMed, Embase …

Purpose This systematic review and meta-analysis aimed to evaluate the effect of
sofosbuvir/daclatasvir (SOF/DCV) on mortality, the need for intensive care unit (ICU) …

Background Different approaches have been proved effective for combating the COVID-19
pandemic. Accordingly, in silico drug repurposing strategy, has been highly regarded as an …

Study Background & Objective: After the influenza pandemic (1918), COVID-19 was
declared a Vth pandemic by the WHO in 2020. SARS-CoV-2 is an RNA-enveloped single …